These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 26517259)

  • 1. Computational Design of Hypothetical New Peptides Based on a Cyclotide Scaffold as HIV gp120 Inhibitor.
    Sangphukieo A; Nawae W; Laomettachit T; Supasitthimethee U; Ruengjitchatchawalya M
    PLoS One; 2015; 10(11):e0139562. PubMed ID: 26517259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermal, chemical, and enzymatic stability of the cyclotide kalata B1: the importance of the cyclic cystine knot.
    Colgrave ML; Craik DJ
    Biochemistry; 2004 May; 43(20):5965-75. PubMed ID: 15147180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the cyclic peptide backbone in the anti-HIV activity of the cyclotide kalata B1.
    Daly NL; Gustafson KR; Craik DJ
    FEBS Lett; 2004 Sep; 574(1-3):69-72. PubMed ID: 15358541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of conserved Glu residue on cyclotide stability and activity: a structural and functional study of kalata B12, a naturally occurring Glu to Asp mutant.
    Wang CK; Clark RJ; Harvey PJ; Rosengren KJ; Cemazar M; Craik DJ
    Biochemistry; 2011 May; 50(19):4077-86. PubMed ID: 21466163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational discovery of novel HIV-1 entry inhibitors based on potent and broad neutralizing antibody VRC01.
    Andrianov AM; Kashyn IA; Tuzikov AV
    J Mol Graph Model; 2015 Sep; 61():262-71. PubMed ID: 26298811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformation and mode of membrane interaction in cyclotides. Spatial structure of kalata B1 bound to a dodecylphosphocholine micelle.
    Shenkarev ZO; Nadezhdin KD; Sobol VA; Sobol AG; Skjeldal L; Arseniev AS
    FEBS J; 2006 Jun; 273(12):2658-72. PubMed ID: 16817894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclotides as natural anti-HIV agents.
    Ireland DC; Wang CK; Wilson JA; Gustafson KR; Craik DJ
    Biopolymers; 2008; 90(1):51-60. PubMed ID: 18008336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities.
    Henriques ST; Huang YH; Rosengren KJ; Franquelim HG; Carvalho FA; Johnson A; Sonza S; Tachedjian G; Castanho MA; Daly NL; Craik DJ
    J Biol Chem; 2011 Jul; 286(27):24231-41. PubMed ID: 21576247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational studies identifying entry inhibitor scaffolds targeting the Phe43 cavity of HIV-1 gp120.
    Tintori C; Selvaraj M; Badia R; Clotet B; Esté JA; Botta M
    ChemMedChem; 2013 Mar; 8(3):475-83. PubMed ID: 23404750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, structural and functional characterization of novel melanocortin agonists based on the cyclotide kalata B1.
    Eliasen R; Daly NL; Wulff BS; Andresen TL; Conde-Frieboes KW; Craik DJ
    J Biol Chem; 2012 Nov; 287(48):40493-501. PubMed ID: 23012369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphatidylethanolamine binding is a conserved feature of cyclotide-membrane interactions.
    Henriques ST; Huang YH; Castanho MA; Bagatolli LA; Sonza S; Tachedjian G; Daly NL; Craik DJ
    J Biol Chem; 2012 Sep; 287(40):33629-43. PubMed ID: 22854971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disulfide mapping of the cyclotide kalata B1. Chemical proof of the cystic cystine knot motif.
    Göransson U; Craik DJ
    J Biol Chem; 2003 Nov; 278(48):48188-96. PubMed ID: 12960160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico design of novel broad anti-HIV-1 agents based on glycosphingolipid β-galactosylceramide, a high-affinity receptor for the envelope gp120 V3 loop.
    Andrianov AM; Kornoushenko YV; Kashyn IA; Kisel MA; Tuzikov AV
    J Biomol Struct Dyn; 2015; 33(5):1051-66. PubMed ID: 24942968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic scenario of membrane binding process of kalata b1.
    Nawae W; Hannongbua S; Ruengjitchatchawalya M
    PLoS One; 2014; 9(12):e114473. PubMed ID: 25473840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chemistry of cyclotides.
    Craik DJ; Conibear AC
    J Org Chem; 2011 Jun; 76(12):4805-17. PubMed ID: 21526790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical synthesis and biosynthesis of the cyclotide family of circular proteins.
    Gunasekera S; Daly NL; Anderson MA; Craik DJ
    IUBMB Life; 2006 Sep; 58(9):515-24. PubMed ID: 17002979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cyclotides: novel macrocyclic peptides as scaffolds in drug design.
    Craik DJ; Simonsen S; Daly NL
    Curr Opin Drug Discov Devel; 2002 Mar; 5(2):251-60. PubMed ID: 11926131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of a novel cyclotide-based CXCR4 antagonist with anti-human immunodeficiency virus (HIV)-1 activity.
    Aboye TL; Ha H; Majumder S; Christ F; Debyser Z; Shekhtman A; Neamati N; Camarero JA
    J Med Chem; 2012 Dec; 55(23):10729-34. PubMed ID: 23151033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solution structure by NMR of circulin A: a macrocyclic knotted peptide having anti-HIV activity.
    Daly NL; Koltay A; Gustafson KR; Boyd MR; Casas-Finet JR; Craik DJ
    J Mol Biol; 1999 Jan; 285(1):333-45. PubMed ID: 9878410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-Silico Template Selection of In-Vitro Evolved Kalata B1 of Oldenlandia Affinis for Scaffolding Peptide-Based Drug Design.
    Senthilkumar B; Kumar P; Rajasekaran R
    J Cell Biochem; 2016 Jan; 117(1):66-73. PubMed ID: 26052694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.